Company intelligence / Profile preview
Astellas Pharma Global Development, Inc.
Northbrook, Illinois, United Statesastellas.com ↗
- Ownership
- Private
- Employees
- ~15000
- Development stage
- Other
01
Overview
Astellas has a broad commercial portfolio (oncology, urology, transplantation, nephrology) and 19 R&D projects targeting priority and non-communicable diseases; 6 programs are in late-stage development including access-focused global health initiatives
- Therapeutic areas
- NephrologyMen's HealthInfectious DiseasesOncologyNeurology
- Modalities
- Small moleculeBiologicMonoclonal antibodyAntibody-drug conjugateGene therapyCell therapy
- Industry
- Pharma
02
Drug pipeline
10 assets9 more assets in the full pipeline.
03
Partnerships
Cytokinetics (skeletal muscle diseases)Pediatric Praziquantel Consortium (schistosomiasis)Mitsubishi Research Institute (Japan pharma startup collaboration)
Beyond the preview
Go deeper on Astellas Pharma Global Development, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Astellas Pharma Global Development, Inc..